Heidelberg Pharma Valuation
| HPHA Stock | EUR 2.41 0.04 1.63% |
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Heidelberg Pharma regular Real Value cannot be determined due to lack of data. The prevalent price of Heidelberg Pharma is €2.41. Our model calculates the value of Heidelberg Pharma from evaluating the firm fundamentals such as EBITDA of (24.84 M), current valuation of 194.72 M, and Price To Book of 24.79 X as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Heidelberg Pharma's price fluctuation is out of control at this time. Calculation of the real value of Heidelberg Pharma is based on 3 months time horizon. Increasing Heidelberg Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Heidelberg stock is determined by what a typical buyer is willing to pay for full or partial control of Heidelberg Pharma AG. Since Heidelberg Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Heidelberg Stock. However, Heidelberg Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.41 | Real 0.0 | Hype 0.0 | Naive 2.62 |
The real value of Heidelberg Stock, also known as its intrinsic value, is the underlying worth of Heidelberg Pharma Company, which is reflected in its stock price. It is based on Heidelberg Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Heidelberg Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Heidelberg Pharma AG helps investors to forecast how Heidelberg stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Heidelberg Pharma more accurately as focusing exclusively on Heidelberg Pharma's fundamentals will not take into account other important factors: Heidelberg Pharma Total Value Analysis
Heidelberg Pharma AG is currently forecasted to have takeover price of 194.72 M with market capitalization of 173.26 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Heidelberg Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
194.72 M | 173.26 M |
Heidelberg Pharma Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Heidelberg indicates not a very effective usage of assets in January.Heidelberg Pharma Profitability Analysis
The company reported the revenue of 1.75 M. Net Loss for the year was (26.14 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Heidelberg Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Heidelberg Pharma and how it compares across the competition.
About Heidelberg Pharma Valuation
The stock valuation mechanism determines Heidelberg Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Heidelberg Pharma. We calculate exposure to Heidelberg Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Heidelberg Pharma's related companies.8 Steps to conduct Heidelberg Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Heidelberg Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Heidelberg Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Heidelberg Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Heidelberg Pharma's revenue streams: Identify Heidelberg Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Heidelberg Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Heidelberg Pharma's growth potential: Evaluate Heidelberg Pharma's management, business model, and growth potential.
- Determine Heidelberg Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Heidelberg Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Heidelberg Stock analysis
When running Heidelberg Pharma's price analysis, check to measure Heidelberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heidelberg Pharma is operating at the current time. Most of Heidelberg Pharma's value examination focuses on studying past and present price action to predict the probability of Heidelberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heidelberg Pharma's price. Additionally, you may evaluate how the addition of Heidelberg Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |